Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUS versus injectable hormonal therapy for persistent abnormal uterine bleeding after tubal ligation
PACTR202608685167118Phase 4Not yet recruiting
- Sponsor
- Faculty of Medicine, Minia University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of avatrombopag in menstrual disorders (2 arms), sponsored by Faculty of Medicine, Minia University. Primary endpoint: Change in menstrual blood loss. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on PACTR202608685167118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608685167118.